(14971513), A. O., (14971516), R. C., (14971519), G. v. A., (14971522), C. R., (14971525), S. F., (14971528), W. L., . . . (14971558), M. J. (2025). Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.
Čikaški stil citiranja (17. izdanje)(14971513), Aurelius Omlin, et al. Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.
MLA način citiranja (9. izdanje)(14971513), Aurelius Omlin, et al. Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.